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Abstract: We examined the effects of various concentrations of the bupivacaine commonly used for spinal anaesthesia on the
reversibility of conduction block in isolated frog sciatic nerves measured by the extracellular recording technique. Seventy-two
isolated nerves were divided into 3 groups (n = 24), each of which was bathed in a different bupivacaine solution in a range of
concentrations (10, 20 or 30 mM for 20 min). In each group, the extracellular action potentials were recorded before exposure to
the bupivacaine solution to provide the control data. The extracellular action potentials were recorded after 20 min exposure to the
drug by using a BIOPAC MP 100 acquisition system version 3.5.7 (Santa Barbara, USA). The nerves were washed continuously for
3 h with Ringer’s solution and action potentials were recorded. The nerves were then soaked overnight at room temperature in
Ringer’s solution and tested for impulse recovery. The data were analysed with repeated-measures analysis of variance using SPSS
9.05 for Windows. In the presence of 10 mM, 20 mM or 30 mM bupivacaine, the extracellular action potential amplitude decreased
by 23.21 ± 12.42%, 28.42 ± 17.51% and 39.45 ± 22.16%, respectively, relative to the control amplitude (P < 0.05); it recovered
to 89.21 ± 50.00%, 66.43 ± 30.10% and 47.12 ± 37.51% (P < 0.05), respectively, after 3-h of wash, and reached 110.31 ±
50.13%, 90.60 ± 43.21% and 130.43 ± 56.32% (P < 0.05), respectively, after the overnight soaking process. This study showed
that exposing the nerve to high concentrations of bupivacaine causes an reversible impulse blockade and that bupivacaine does not
have neurotoxic effects on isolated frog sciatic nerves.
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Introduction
Local anaesthetics block the propagation of nerve
impulses by binding to receptors on the Na channel and
preventing normal functioning (1). This binding appears
to involve a single local anaesthetic molecule (2) and to be
based on the concentration of local anaesthetic required
to bring about 50% inhibition of the Na+ current.
Bupivacaine hydrochloride (amide local anaesthetic) is
the most frequently used local anaesthetic for
preoperative and postoperative pain relief in many
countries. It is a potent agent capable of producing
prolonged anaesthesia. Its long duration of effectiveness
plus its tendency to provide more sensory than motor
blocking has made it a popular drug for providing
prolonged anaesthesia during labour or the postoperative
period (3).

Direct exposure of the cauda equina to high
concentrations of local anaesthetics during continuous
spinal and epidural anaesthesia may have caused the
recently reported cases of cauda equina syndrome (4-6).
Since anaesthesiologists cannot predict how
cerebrospinal fluid will dilute administered drugs, the
appropriate modification to ensure safe practice would be
to give concentrations of drugs that in themselves never
exceed a safe concentration. It is therefore important to
identify a concentration below which the nerve is not
irreversibly affected. Thus we sought the effects of
various concentrations of the bupivacaine commonly used
for spinal anaesthesia on the reversibility of conduction
block in isolated frog sciatic nerves.
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Materials and Methods
Tissue preparation
Seventy-two Rana cameroni frogs weighing 30-40 g
were used in the experiments. The sciatic nerves were
excised from rapidly decapitated and pithed frogs and
maintained in Ringer’s solution. This solution was
composed of 111.87 mM NaCl, 2.47 mM KCl, 1.08 mM
CaCl2 and 2.38 mM NaHCO3. The isolated nerves (n = 72)
were randomly divided into 3 groups (n = 24 in each
group): group I; 10 mM (0.32% bupivacaine solution),
group II; 20 mM (0.65% bupivacaine solution) and group
III; 30 mM (0.97% bupivacaine solution). The pH of the
Ringer’s solution was adjusted to 7.2 and all
measurements were recorded with the preparations
equilibrated at room temperature (21-23 °C). The
bupivacaine hydrochloride used in this experiment was
purchased from Sigma Chemical (B-5274). The drug was
dissolved in frog Ringer’s solution.
Electrophysiological techniques
The experiments were carried out in vitro using extracellular recording techniques (7,8). After 30 min of
stabilisation in Ringer’s solution, segments of nerve
measuring 3-4 cm were placed in a 5 cm x 15 cm
Plexiglas nerve chamber containing Ag/AgCl electrodes.
The electrodes were 0.5 cm apart. The stimulating
voltage was set to produce a maximal compound action
potential using single square pulses of supra-maximal
strength and 0.5 ms in duration.
Experimental protocols
After the compound nerve action potential (CNAP)
had stabilised in Ringer’s solution, CNAPs were recorded
using a BIOPAC MP100 acquisition system version 3.5.7
(Santa Barbara, USA) from each nerve before exposure to
0.32%, 0.65% or 0.97% bupivacaine solution and these
data were treated as the control (experiment I). Each
nerve was bathed for 20 min in the bupivacaine solution
for each group. After the 20-min drug exposure, CNAPs
were recorded (experiment II). Then the nerves were
washed (exposed to the drug) continuously with Ringer’s
solution for 3 h and CNAPs were again recorded
(experiment III). The nerves were then removed from the
chamber and soaked overnight at room temperature in
100 ml Ringer’s solution. The next morning (24-h after
the drug exposure), the nerves were replaced in the nerve
chamber and were tested for impulse recovery
(experiment IV).
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Statistical analysis
The same subject groups were observed 4 times using
the repeated-measures design. In this design, each subject
serves as its own control. After testing normal
distribution with the Kolmogorov-Smirnov method, the
data were analysed with the repeated-measure analysis of
variance by using SPSS 9.05 for Windows. Least
significant difference (LSD) was used for post hoc tests.
The significance was set at P < 0.05.

Results
The amplitude of a given CNAP was defined as the
height in millivolts from the peak of positive phase to
peak of the negative phase. In the presence of bupivacaine
the CNAP amplitude decreased, relative to the control
amplitude (P < 0.05), but we observed recovery of the
CNAP after 3- and 24-h washes in anaesthetic-free
Ringer’s solution in all groups (P < 0.05). In nerves
exposed to 10 mM, 20 mM or 30 mM bupivacaine
hydrochloride, the extracellular action potential amplitude
decreased by 23.21 ± 12.42%, 28.42 ± 17.51% or
39.45 ± 22.16% respectively, relative to the control
amplitude (P < 0.05). It then recovered to 89.21 ±
50.00%, 66.43 ± 30.10% or 47.12 ± 37.51% (P <
0.05), respectively, after 3 h of wash, and reached
110.31 ± 50.13%, 90.60 ± 43.21% or 130.43 ±
56.32% (P < 0.05), respectively, after the overnight
soak process. (Table). The effects of 10 mM and 30 mM
concentrations of bupivacaine applied extracellularly to
sciatic nerve action potentials are shown in Figure 1. As
seen in this figure, the amplitude of action potential was
depressed in these concentrations, but after 3- and 24-h
washes the nerves recovered to the control values.
Figures 2 and 3 show the mean recovery of the CNAP for
different concentrations of bupivacaine after 3- and 24-h
washes.

Discussion
This study confirms that the CNAP recorded in the
frog sciatic nerve is reversibly eliminated by 20 min
exposure to 3 different concentrations of bupivacaine.
This reversible inhibition is due to the fact that local
anaesthetics block the propagation of nerve impulses by
binding to receptors on the sodium channel and
preventing normal functioning (1).
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Control (before bupivacaine)

Bupivacaine

After 3-h wash

After 24-h wash

10 mM bupivacaine

30 mM bupivacaine

Figure 1. Effects of 10 mM (a) and 30 mM (b) bupivacaine on CNAP and recovery of CNAP after 3-h and 24-h washes
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Figure 2. Mean recovery of CNAP after 3-h wash with Ringer’s solution for different concentrations of bupivacaine applications. (CI: confidence
interval)

Bupivacaine is the most frequently used drug for
spinal anaesthesia. In reported cases of cauda equina
syndrome after continuous spinal anaesthesia it was

suggested that highly concentrated local anaesthetics
were responsible (4,5). Studies of spinal canal models
show that slow injection through misdirected intrathecal
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Figure 3. Mean recovery of CNAP after 24-h wash with Ringer’s solution for different concentrations of bupivacaine applications. (CI: confidence
interval)

catheters may cause nonhomogenous mixing of local
anaesthetic with the cerebrospinal fluid (9-11). As a
result, the relatively unprotected nerve fibres of the
cauda equina may be unintentionally and directly exposed
to a high concentration of local anaesthetic.
Bupivacaine is commonly used in 0.5-0.75%
concentrations for spinal anaesthesia (12). It has been
reported that bupivacaine solution at 0.75%
concentration causes partially reversible conduction block
(12). Based on this finding, Lambert et al. suggested that
bupivacaine could not cause cauda equina syndrome
caused by irreversible conduction block.

The present study did not evaluate the potential
neurotoxicity of such high concentrations of bupivacaine.
Lambert et al. (12) found that nerves exposed to 0.75%
bupivacaine for 15 min recovered to nearly 76 ± 3%
after 3-h of wash and 44 ± 8% after soaking overnight.
In our study, we used a higher bupivacaine dose and a
longer exposure than Lambert et al. However, we found
that highly concentrated bupivacaine has no toxic effect
on frog sciatic nerves, since nerves exposed to 0.97%
bupivacaine for 20 min recovered approximately 50%
impulse activity during the 3-h wash and nearly
completely during the 24-h wash.

It is not known whether the effect of bupivacaine on
neural substrates at higher concentrations is reversible.
To answer this question, we chose a higher dose than
that used in clinics as the upper limit in our study.

In present study, the nerves exposed to 0.32-0.97%
bupivacaine showed an apparently greater recovery after
the 24-h wash than the control nerves (Table). In
addition, Lambert et al. (12) found that nerves exposed

Table.

Percentage of CNAP amplitude decrease relative to the control amplitude in the presence of bupivacaine and the recovery of CNAP after 3h and 24-h washes.

Dose (mM)

Decrease in CNAP
amplitude in the
presence of bupivacaine

Recovery of
CNAP after 3-h wash

Recovery of
CNAP after 24-h wash

10
20
30

23.21 ± 12.42
28.42 ± 17.51
39.45 ± 22.16

89.21 ± 50.00
66.43 ± 30.10
47.12 ± 37.51

110.31 ± 50.13
90.60 ± 43.21
130.43 ± 56.32
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to 0.06% tetracaine exhibited an apparently greater
recovery than the control nerves. This observed greater
recovery than in the control nerves remains unexplained.
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In conclusion, this study shows that exposing frog
myelinated sciatic nerves to high concentrations of
bupivacaine causes an reversible impulse blockade and
that bupivacaine does not have any neurotoxic effects on
isolated frog sciatic nerves.
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